Aliases & Classifications for Dysthymic Disorder

About this section

Aliases & Descriptions for Dysthymic Disorder:

Name: Dysthymic Disorder 10 12 36 65
 
Dysthymia 10 47

Classifications:



External Ids:

Disease Ontology10 DOID:12139
ICD1027 F34.1
ICD9CM29 300.4
SNOMED-CT59 192384008, 78667006
MeSH36 D019263
NCIt42 C34562
UMLS65 C0013415

Summaries for Dysthymic Disorder

About this section
Wikipedia:68 Dysthymia (/dɪsˈθaɪmiə/ dis-THY-mee-ə, from Ancient Greek δυσθυμία, \"bad state of... more...

MalaCards based summary: Dysthymic Disorder, also known as dysthymia, is related to personality disorder and ring chromosome 14 syndrome, and has symptoms including feeling despair An important gene associated with Dysthymic Disorder is HTR2A (5-Hydroxytryptamine Receptor 2A), and among its related pathways are Monoamine Transport and SIDS Susceptibility Pathways. Affiliated tissues include prostate, brain and spinal cord, and related mouse phenotypes are integument and homeostasis/metabolism.

Disease Ontology:10 A mood disorder that involves the presence of a low mood almost daily over a span of at least two years.

Related Diseases for Dysthymic Disorder

About this section

Diseases related to Dysthymic Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 99)
idRelated DiseaseScoreTop Affiliating Genes
1personality disorder30.6CRH, HTR2A, MAOA
2ring chromosome 14 syndrome10.6HTR2A, MAOA
3ehrlichiosis10.6HTR2A, MAOA
4kleptomania10.6HTR2A, MAOA
5miller fisher syndrome10.6GATA3, HTR2A
6deafness and myopia10.5HTR2A, MAOA
7endometrial small cell carcinoma10.4GATA3, HTR2A
8nodular episcleritis10.4CRH, HTR2A
9acute sphenoidal sinusitis10.4CRH, HTR2A
10multiple personality disorder10.4HTR2A, SLC6A4
11neurodegeneration with optic atrophy, childhood onset10.4HTR2A, SLC6A4
12kluver-bucy syndrome10.4HTR2A, SLC6A4
13prostate adenocarcinoma10.3HTR2A, SLC6A4
14uterine corpus adenomatoid tumor10.3HTR2A, SLC6A4
15exostosis10.3HTR2A, SLC6A4
16geniculate herpes zoster10.3HTR2A, SLC6A4
17cat-scratch disease10.3MAOA, SLC6A4
18hereditary myopathy with lactic acidosis due to iscu deficiency10.3MAOA, SLC6A4
19anxiety disorder10.3
20intracranial aneurysm10.2MAOA, SLC6A4
21attention deficit-hyperactivity disorder10.2
22tabes dorsalis10.2HTR2A, SLC6A4
23neonatal myasthenia gravis10.2HTR2A, SLC6A4
24liver leiomyoma10.2HTR2A, HTR7
25hairy cell leukemia10.2CRH, HTR2A, MAOA
26coronary thrombosis10.2HTR2A, HTR7
27steatorrhea10.1HTR2A, HTR7
28heroin dependence10.1HTR2A, SLC6A4
29inner ear disease10.1HTR2A, HTR7
30bladder lateral wall cancer10.1HTR2A, HTR7
31panuveitis10.1HTR2A, HTR7
32conjunctiva squamous cell carcinoma10.1HTR2A, HTR7
33c1 inhibitor deficiency10.1HTR2A, HTR7
34generalized anxiety disorder10.1
35periampullary adenoma10.1HTR2A, SLC6A4
36adrenal cortical adenoma10.1HTR2A, MAOA
37acute dacryocystitis10.1MAOA, SLC6A4
38gastric pylorus carcinoma10.1HTR2A, HTR7
39lactocele10.1HTR2A, HTR7
40hypolipoproteinemia10.1HTR2A, HTR7
41brachial plexus neoplasm10.1HTR2A, MAOA, SLC6A4
42perrault syndrome10.1HTR2A, MAOA, SLC6A4
43bipolar ll disorder10.1HTR2A, HTR7
44ovarian mixed germ cell neoplasm10.1HTR2A, MAOA, SLC6A4
45zebra body myopathy10.1HTR2A, MAOA, SLC6A4
46atypical depressive disorder10.1HTR2A, MAOA, SLC6A4
47dependent personality disorder10.1HTR2A, MAOA, SLC6A4
48plasmodium malariae malaria10.1HTR2A, MAOA, SLC6A4
49chronic gonorrhea of cervix10.0HTR2A, MAOA, SLC6A4
50phonagnosia10.0HTR2A, HTR7

Comorbidity relations with Dysthymic Disorder via Phenotypic Disease Network (PDN):

(show top 50)    (show all 55)
Anxiety DisorderAtypical Depressive Disorder
Conversion DisorderDeficiency Anemia
Delusional DisorderActive Peptic Ulcer Disease
Acute CystitisAdjustment Disorder
Atrophic GastritisAvoidant Personality Disorder
Benign Essential HypertensionBorderline Personality Disorder
BronchitisChronic Pulmonary Heart Disease
Coronary Artery DiseaseDependent Personality Disorder
Dyskinesia of EsophagusEsophagitis
Familial Atrial FibrillationGastritis
Generalized AtherosclerosisHeart Disease
Histrionic Personality DisorderHypertension, Essential
HypochondriasisIntermediate Coronary Syndrome
Irritable Bowel SyndromeIschemic Heart Disease
Mitral Valve DiseaseNarcissistic Personality Disorder
Obsessive-Compulsive Personality DisorderOpiate Dependence
Orthostatic IntoleranceOsteoarthritis
OsteoporosisParalytic Ileus
Parkinson Disease, Late-OnsetPeripheral Vascular Disease
Personality DisorderPostinflammatory Pulmonary Fibrosis
Post-Traumatic Stress DisorderRespiratory Failure
Somatization DisorderTardive Dyskinesia
Transient Cerebral IschemiaGeneralized Anxiety Disorder
HypothyroidismIron Deficiency Anemia
Major Depressive Disorder and Accelerated Response to Antidepressant Drug TreatmentMood Disorder

Graphical network of the top 20 diseases related to Dysthymic Disorder:



Diseases related to dysthymic disorder

Symptoms for Dysthymic Disorder

About this section

UMLS symptoms related to Dysthymic Disorder:


feeling despair

Drugs & Therapeutics for Dysthymic Disorder

About this section

Drugs for Dysthymic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 89)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
NorepinephrineapprovedPhase 4, Phase 259551-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
 
LT03330026
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
2
Paroxetineapproved, investigationalPhase 4, Phase 222161869-08-743815
Synonyms:
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
Brisdelle
C07415
C19H20FNO3
CHEBI:7936
CHEMBL490
CID43815
Casbol
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
FT-0085087
Frosinor
 
HMS2090H05
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
Paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine Hcl
Paroxetine Hydrochloride
Paroxetine Mesylate
Paroxetine [USAN:INN:BAN]
Paroxetinum
Paroxetinum [INN-Latin]
PaxPar
Paxetil
Paxil
Paxil CR
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum5_001665
Spectrum_001752
TL8003967
UNII-41VRH5220H
[3H]Paroxetine
paroxetine
3
ImipramineapprovedPhase 42750-49-73696
Synonyms:
1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine
10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine
10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine
10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine
113-52-0 (mono-hydrochloride)
2,2'-(3-Dimethylaminopropylimino)bibenzyl
2,2'-(3-Dimethylaminopropylimino)dibenzyl
3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine
3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine
5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine
5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine
5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine
5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine
5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine
50-49-7
5H-Dibenz(b,f)azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl- (9CI)
AB00053486
AC1L1GIE
Antideprin
BIDD:GT0116
BPBio1_000313
BRD-K38436528-003-05-5
BRN 0256892
BSPBio_000283
BSPBio_002172
Berkomine
C07049
CAS-113-52-0
CCRIS 9173
CHEBI:47499
CHEMBL11
CID3696
CPD-11438
Censtim
Censtin
Chimoreptin
D08070
DB00458
DB08002
DPID
Declomipramine
Dimipressin
DivK1c_000559
Dpid
Dyna-Zina
Dyna-zina
Dynaprin
EINECS 200-042-1
Estraldine
Eupramin
Feinalmin
G-22355
HMS2089G08
HSDB 3100
IDI1_000559
IM
Imavate
Imidobenzyle
Imilanyle
Imipramin
Imipramina
Imipramina [INN-Spanish]
Imipramina [Italian]
Imipramine
Imipramine (INN)
Imipramine Hcl
Imipramine Hydrochloride
Imipramine Pamoate
Imipramine [INN:BAN]
Imipraminum
Imipraminum [INN-Latin]
Imiprin
Imizin
Imizine
Imizinum
 
Impramine
InChI=1/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H
Intalpram
Iramil
Irmin
Janimine
Janimine (hydrochloride)
KBio1_000559
KBio2_001395
KBio2_003963
KBio2_006531
KBio3_001392
KBioGR_000391
KBioSS_001395
L000739
LS-60467
Lofepramine
Lopac-I-7379
Lopac0_000702
Melipramin
Melipramine
MolPort-001-783-692
N-(.gamma.-Dimethylaminopropyl)iminodibenzyl
N-(3-Dimethylaminopropyl)-o-iminodibenzyl
N-(gamma-Dimethylaminopropyl)iminodibenzyl
N-(γ-dimethylaminopropyl)iminodibenzyl
NCGC00015563-01
NCGC00015563-02
NCGC00015563-03
NCGC00015563-09
NCGC00024253-03
NCGC00024253-04
NINDS_000559
NSC 169866
NSC169866
Nelipramin
Norchlorimipramine
Norfranil
Oprea1_200908
Pramine
Prazepine
Presamine
Prestwick0_000072
Prestwick1_000072
Prestwick2_000072
Prestwick3_000072
Promiben
Psychoforin
SK-Pramine
SPBio_001059
SPBio_002204
Sk-Pramine
Spectrum2_000990
Spectrum3_000466
Spectrum4_000016
Spectrum5_000864
Spectrum_000915
Surmontil
Surplix
Teperine
Timolet
Tipramine
Tofranil
Tofranil (TN)
Tofranil (free base)
Tofranil (hydrochloride)
Tofranil base
Tofranil, Base
Tofranil, base
Tofranil-PM (imipramine pamoate)
Tofranil-Pm
Tofranil-pm
Tofraniln A
Trimipramine Maleate
UNII-OGG85SX4E4
WLN: T C676 BN&T&J B3N1&1
imipramine
nchembio747-comp8
4
CitalopramapprovedPhase 4, Phase 2, Phase 349459729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Perrigo Citalopram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
5
Modafinilapproved, investigationalPhase 419268693-11-84236
Synonyms:
Dea No. 1680
Modafinil
Modafinil [USAN:INN]
Modafinil [Usan:Inn]
Modafinilo
Modafinilo [Spanish]
 
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Provigil
Sparlon
modafinil
6
SertralineapprovedPhase 4, Phase 2, Phase 328279617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
CP 51974
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-Sertraline
sertraline
sertraline (Zoloft)
7
FluoxetineapprovedPhase 4, Phase 2, Phase 322954910-89-33386
Synonyms:
(+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+/-)-Fluoxetine
(+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine
(+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine]
(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine
3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
52341-67-0
54910-89-3
57226-07-0
59333-67-4 (hydrochloride)
AB00053774
AC-14564
AC1L1FTH
AKOS003663021
Adofen
Animex-On
BPBio1_000354
BPBio1_000509
BRD-A31159102-001-01-9
BRD-A31159102-003-05-6
BSPBio_000461
BSPBio_003375
Bio-0787
Biomol-NT_000152
C17H18F3NO
CHEBI:5118
CHEMBL41
CID3386
D00326
DB00472
Deprex
DivK1c_006819
Eufor
Floxetine
Fluctin
Fluoxeren
Fluoxetin
Fluoxetina
Fluoxetina [INN-Spanish]
Fluoxetina [Spanish]
Fluoxetine
Fluoxetine (TN)
Fluoxetine (USAN/INN)
Fluoxetine Hcl
Fluoxetine Hydrochloride
Fluoxetine [USAN:INN:BAN]
Fluoxetinum
 
Fluoxetinum [INN-Latin]
Fluoxétine
Fluval
Fontex
Foxetin
HMS2090H14
KBio1_001763
KBio2_002159
KBio2_004727
KBio2_007295
KBio3_002595
KBioGR_001166
KBioSS_002159
L000931
LS-31040
Lilly-110140
Lopac0_000558
Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine
Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine
MolPort-001-683-482
N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine
NCGC00015428-10
NCGC00024879-03
NCGC00024879-04
NSC283480
Portal
Prestwick0_000511
Prestwick1_000511
Prestwick2_000511
Prestwick3_000511
Prozac
Prozac Weekly
Pulvules
Reconcile
Reneuron
SPBio_001815
SPBio_002382
STK734483
Sarafem
SpecPlus_000723
Spectrum2_001658
Spectrum3_001648
Spectrum4_000613
Spectrum5_001518
Spectrum_001679
TL8003595
UNII-01K63SUP8D
dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
fluoxetine
fluoxetine (Prozac)
nchembio.534-comp2
8
BupropionapprovedPhase 4, Phase 2, Phase 330834841-39-9444
Synonyms:
( -)-2-(tert-Butylamino)-3'-chloropropiophenone
( -)-2-(tert-Butylamino)-3'-chlorpropiophenon
(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
.alpha.-(tert-Butylamino)-m-chloropropiophenone
1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one
2-(Tert-Butylamino)-3'-chloropropiophenone
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
34841-36-6 (hydrochloride)
34841-39-9
34911-55-2
AB00053756
AC-197
AC1L198Y
AMFEBUTAMONE HCl
Amfebutamon
Amfebutamona
Amfebutamona [INN-Spanish]
Amfebutamone
Amfebutamonum
Amfebutamonum [INN-Latin]
Aplenzin
BPBio1_000042
BRD-A05186015-003-05-7
BRN 2101062
BSPBio_000038
BSPBio_002247
Budeprion
Buproban
Bupropion
Bupropion (INN)
Bupropion (Old RN)
Bupropion (USAN)
Bupropion Hcl
Bupropion Hydrochloride
Bupropion SR
Bupropion [INN:BAN]
Bupropion hydrocloride
C06860
CHEBI:3219
CHEMBL894
CID444
CPD000472526
D07591
DB01156
 
DivK1c_007050
Elont
HMS2051G10
HMS2089G14
Jsp006301
KBio1_001994
KBio2_002143
KBio2_004711
KBio2_007279
KBio3_001467
KBioGR_001168
KBioSS_002143
L000725
LS-122817
Lopac0_000166
MLS001424015
MolPort-003-845-432
NCGC00015122-06
NCGC00089751-02
NCI60_002714
NSC315851
Prestwick0_000249
Prestwick1_000249
Prestwick2_000249
Prestwick3_000249
SAM001246699
SMR000472526
SPBio_001817
SPBio_002257
SpecPlus_000954
Spectrum2_001659
Spectrum3_000644
Spectrum4_000614
Spectrum5_001406
Spectrum_001663
TL8002604
UNII-01ZG3TPX31
Wellbatrin
Wellbutrin
Wellbutrin SR
Wellbutrin XL
Wellbutrin Xl
Zyban
alpha-(tert-butylamino)-m-chloropropiophenone
amfebutamonum
bupropion
9
DopamineapprovedPhase 4308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
10
Testosteroneapproved, investigationalPhase 447458-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
Aveed
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depo-testosterone
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Fortesta
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
Intrinsa
 
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Natesto nasal gel
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Gel
Testosterone Heptanoate
Testosterone Hydrate
Testosterone Propionate
Testosterone Undecanoate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Vogelxo
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
11
MethyltestosteroneapprovedPhase 447458-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
12
DonepezilapprovedPhase 4271120014-06-43152
Synonyms:
( inverted exclamation markA)-E 2020
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
120014-06-4
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC-6969
AC1L1FAE
AKOS000277311
Aricept
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
 
Donepezil
Donepezil (INN)
Donepezil Hydrochloride
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum5_001662
Spectrum_001664
TL8000531
UNII-8SSC91326P
13Antidepressive Agents, TricyclicPhase 4250
14Adrenergic AgentsPhase 4, Phase 24204
15Contraceptives, OralPhase 4, Phase 23734
16Wakefulness-Promoting AgentsPhase 4179
17Tranquilizing AgentsPhase 4, Phase 3, Phase 23597
18Venlafaxine HydrochloridePhase 4, Phase 2, Phase 3185
19Phosphodiesterase 5 InhibitorsPhase 4513
20Sildenafil CitratePhase 4304171599-83-0
21Vasodilator AgentsPhase 42926
22Antipsychotic AgentsPhase 42130
23Central Nervous System StimulantsPhase 4, Phase 1, Phase 21721
24Desvenlafaxine SuccinatePhase 467386750-22-7
25Antidepressive AgentsPhase 4, Phase 3, Phase 2, Phase 12367
26Phosphodiesterase InhibitorsPhase 41062
27Central Nervous System DepressantsPhase 4, Phase 3, Phase 210016
28Serotonin AgentsPhase 4, Phase 3, Phase 22668
29Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 114795
30Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 22857
31Psychotropic DrugsPhase 4, Phase 3, Phase 2, Phase 15501
32AnalgesicsPhase 49358
33Dopamine Uptake InhibitorsPhase 4925
34Dopamine AgentsPhase 43084
35Antidepressive Agents, Second-GenerationPhase 4, Phase 21087
36Cytochrome P-450 CYP2D6 InhibitorsPhase 4602
37Cytochrome P-450 Enzyme InhibitorsPhase 43036
38Duloxetine HydrochloridePhase 4258
39Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 118510
40Muscarinic AntagonistsPhase 4, Phase 2961
41ParasympatholyticsPhase 4, Phase 2902
42Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 21369
43ArmodafinilPhase 4192
44Cholinergic AntagonistsPhase 4, Phase 21423
45
SerotoninPhase 4, Phase 3, Phase 2314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
46Cholinergic AgentsPhase 4, Phase 2, Phase 13243
47Serotonin and Noradrenaline Reuptake InhibitorsPhase 4, Phase 2391
48Antiparkinson AgentsPhase 4, Phase 21312
49
Testosterone enanthatePhase 4474315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
50Testosterone undecanoatePhase 4474

Interventional clinical trials:

(show top 50)    (show all 71)
idNameStatusNCT IDPhase
1Wellbutrin XL for Dysthymic DisorderCompletedNCT00225251Phase 4
2Duloxetine Treatment in Elderly With DysthymiaCompletedNCT01852383Phase 4
3Escitalopram in the Treatment of Dysthymic Disorder, Double BlindCompletedNCT00220701Phase 4
4Duloxetine for Chronic Depression: a Double-blind StudyCompletedNCT00360724Phase 4
5Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionCompletedNCT00518986Phase 4
6Project to Improve Symptoms and Mood in People With Spinal Cord InjuryCompletedNCT00592384Phase 4
7Treatment of Depression Following Multiple Brain TestsCompletedNCT00296777Phase 4
8Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00296725Phase 4
9Are Two Antidepressants a Good Initial Treatment for Depression?CompletedNCT00296712Phase 4
10Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00404755Phase 4
11A Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionCompletedNCT00296699Phase 4
12Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile DysfunctionCompletedNCT00159809Phase 4
13Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)CompletedNCT00610909Phase 4
14Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized TrialRecruitingNCT00260390Phase 4
15Desvenlafaxine vs. Placebo Treatment of Chronic DepressionRecruitingNCT01537068Phase 4
16Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older AdultsRecruitingNCT01973283Phase 4
17Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersRecruitingNCT00182533Phase 4
18Medications for the Treatment of Dysthymic Disorder and Double DepressionActive, not recruitingNCT00234312Phase 4
19Combination Treatment Study for Memory Impairment and DepressionActive, not recruitingNCT01658228Phase 4
20Switching to Duloxetine to Ameliorate SSRI-Induced Sexual DysfunctionTerminatedNCT00398632Phase 4
21A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older AdultsWithdrawnNCT01942187Phase 4
22A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal BehaviorCompletedNCT01447602Phase 3
23A Stepped Care Model of Adolescent Depression Treatment in Primary CareCompletedNCT01443715Phase 2, Phase 3
24Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT00707980Phase 3
25Treatment of Adolescent Suicide Attempters (TASA)CompletedNCT00080158Phase 2, Phase 3
26A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}RecruitingNCT02358343Phase 3
27Treating Depression Among Low-Income Patients With CancerActive, not recruitingNCT00565110Phase 2, Phase 3
28The Efficacy of Parent Involvement in the Treatment of Adolescent DepressionCompletedNCT00883519Phase 1, Phase 2
29A Safety, Efficacy and Tolerability Study of SEP-225289CompletedNCT00584974Phase 2
30Group Therapy for Women Prisoners With Comorbid Substance Use and DepressionCompletedNCT00606996Phase 2
31Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder SymptomsCompletedNCT01189812Phase 2
32Group Interpersonal Psychotherapy for Depressed Adolescents in School-based ClinicsCompletedNCT00270244Phase 2
33Bringing What Works to Youth in Corrections: A Trauma InterventionCompletedNCT01560728Phase 1, Phase 2
34Computerized Information-Processing Bias Retraining in Depressed AdolescentsCompletedNCT01147913Phase 2
35New Approaches to Cocaine Abuse Medications (A) - 6CompletedNCT00000271Phase 2
36A Study of Omega-3 as a Treatment for Major DepressionRecruitingNCT00238758Phase 2
37Effects of Therapist Behavior on the Treatment of Depressed AdolescentsActive, not recruitingNCT00073359Phase 1, Phase 2
38Smoking Cessation for Depressed SmokersActive, not recruitingNCT00494728Phase 1, Phase 2
39eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed PatientsEnrolling by invitationNCT02458690Phase 2
40Interpersonal Psychotherapy for Depressed Adolescents and ParentsCompletedNCT00619411Phase 1
41Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With DepressionCompletedNCT00356304Phase 1
42Desvenlafaxine Monotherapy in DysthymiaCompletedNCT01948895
43Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E TrialCompletedNCT01583400
44Cognitive Behavioral Therapy (REBT/CBT) Evaluation for Dysthymia in the Practice of Clinical Social Work at Primary CareCompletedNCT02112708
45Quetiapine in Co-Morbid Depressive and Anxiety DisordersCompletedNCT00688818
46Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused InterventionCompletedNCT01542957
47Duloxetine for the Treatment of DysthymiaCompletedNCT00185575
48Improving Depression Care for Elders: Coordinating CenterCompletedNCT01561105
49Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive SymptomsCompletedNCT01892124
50Cognitive Behavioral Therapy for Early-Onset DepressionCompletedNCT00096642

Search NIH Clinical Center for Dysthymic Disorder


Cochrane evidence based reviews: dysthymic disorder

Genetic Tests for Dysthymic Disorder

About this section

Anatomical Context for Dysthymic Disorder

About this section

MalaCards organs/tissues related to Dysthymic Disorder:

33
Prostate, Brain, Spinal cord, Endothelial, Liver, Testes, Pancreatic islet

Animal Models for Dysthymic Disorder or affiliated genes

About this section

MGI Mouse Phenotypes related to Dysthymic Disorder:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107717.7CRH, GATA3, HTR7, IKBKAP, SLC6A4
2MP:00053766.9CINP, CRH, GATA3, HTR7, IKBKAP, MAOA

Publications for Dysthymic Disorder

About this section

Articles related to Dysthymic Disorder:

(show top 50)    (show all 114)
idTitleAuthorsYear
1
Dysthymic disorder in the elderly population. (24152873)
2014
2
L-acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine. (23428336)
2013
3
Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: three case reports. (23724355)
2013
4
Are there meaningful differences between major depressive disorder, dysthymic disorder, and their subthreshold variants? (22922240)
2012
5
Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls. (21312291)
2010
6
The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. (21190638)
2010
7
The effects of dysthymic disorder on health-related quality of life and disability days in persons with comorbid medical conditions in the general population. (19270471)
2009
8
Dysthymic disorder: forlorn and overlooked? (19724735)
2009
9
Comparison of prototypic cases of depressive personality disorder and dysthymic disorder. (18825775)
2008
10
Comparison of psychosocial correlates in primary school age children with attention deficit/ hyperactivity disorder- combined type, with and without dysthymic disorder. (16755402)
2006
11
Characteristics of internalizing and externalizing disorders in medication-naive, clinically referred children with attention deficit hyperactivity disorder, combined type and dysthymic disorder. (15860023)
2005
12
Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder. (15653941)
2005
13
Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients. (15013252)
2004
14
An open treatment trial of venlafaxine for elderly patients with dysthymic disorder. (15533993)
2004
15
A growth curve analysis of the course of dysthymic disorder: the effects of chronic stress and moderation by adverse parent-child relationships and family history. (15612848)
2004
16
Which anxiety disorders may differentiate attention deficit hyperactivity disorder, combined type with dysthymic disorder from attention deficit hyperactivity disorder, combined type alone? (14511084)
2003
17
Nefazodone treatment of dysthymic disorder an open, long-term, prospective pilot study. (12188098)
2002
18
A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes. (12429360)
2002
19
Circadian rhythm of hunger sensation in patients affected by dysthymic disorder. (11963632)
2002
20
Adverse life events in elderly patients with major depression or dysthymic disorder and in healthy-control subjects. (11994213)
2002
21
Dysthymic disorder: treatment with citalopram. (11816048)
2002
22
Dysthymic disorder: integrating research findings into clinical treatment. (15990540)
2001
23
Dysthymic disorder: clinical characteristics in relation to age at onset. (11532531)
2001
24
Parental psychopathology and reports of the childhood home environment in adults with early-onset dysthymic disorder. (10695833)
2000
25
Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study. (10831473)
2000
26
Prevalence of dysthymic disorder in primary care. (10467975)
1999
27
Evaluation of dysthymic disorder with technetium-99 m hexamethylpropylene amine oxime brain single-photon emission tomography. (10079317)
1999
28
Depressive personality in the relatives of outpatients with dysthymic disorder and episodic major depressive disorder and normal controls. (10512602)
1999
29
Dysthymic disorder: treatment with mirtazapine. (10569129)
1999
30
Thirty-month naturalistic follow-up study of early-onset dysthymic disorder: course, diagnostic stability, and prediction of outcome. (9604563)
1998
31
Treatment of dysthymic disorder. (9809214)
1998
32
Platelet MAO activity in patients with dysthymic disorder. (9657421)
1998
33
Venlafaxine in dysthymic disorder. (9448655)
1997
34
Dysthymic disorder in the context of other psychiatric disorders. (9105192)
1997
35
Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. (9160652)
1996
36
Dysthymic disorder: the chronic depression. (8644572)
1996
37
Long-term prognosis of major depression in old age: a comparison with prognosis of dysthymic disorder. (8580393)
1995
38
Dysthymic disorder: a comparison of DSM-IV and ICD-10 and issues in differential diagnosis. (7942063)
1994
39
Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. (8120154)
1993
40
Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. (1541768)
1992
41
Potential value of 5-HT2 receptor antagonists in the treatment of dysthymic disorders]. (1342678)
1992
42
Social and environmental factors and dysthymic disorder in old age. (1619457)
1992
43
Diagnostic criteria for dysthymic disorder. (2697006)
1989
44
Recognition and management of dysthymic disorder. (2679013)
1989
45
Treatment planning. Dysthymic disorder complicated by bouts of major depression. (3596481)
1987
46
A critical discussion of DSM-III dysthymic disorder. (3318511)
1987
47
Dysthymic disorder and rheumatic pain modulation disorder (fibrositis syndrome): a comparison of symptoms and sleep physiology. (3465426)
1986
48
Neuroendocrine and personality variables in dysthymic disorder. (3917618)
1985
49
Depressive disorder in children and adolescents: dysthymic disorder and the use of self-rating scales in assessment. (6510029)
1984
50
Cognitive-behavioral analysis system of psychotherapy: an interactional treatment approach for dysthymic disorder. (6473572)
1984

Variations for Dysthymic Disorder

About this section

Expression for genes affiliated with Dysthymic Disorder

About this section
Search GEO for disease gene expression data for Dysthymic Disorder.

Pathways for genes affiliated with Dysthymic Disorder

About this section

GO Terms for genes affiliated with Dysthymic Disorder

About this section

Biological processes related to Dysthymic Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to ethanolGO:00454719.6CRH, GATA3
2memoryGO:00076139.5HTR2A, SLC6A4
3smooth muscle contractionGO:00069399.5HTR2A, HTR7
4response to drugGO:00424938.3CRH, GATA3, HTR2A, SLC6A4

Sources for Dysthymic Disorder

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet